 Home > Active Ingredient News > Antitumor Therapy > Clinical application guideline for the treatment of chronic prostatitis with Chinese patent medicines

Clinical application guideline for the treatment of chronic prostatitis with Chinese patent medicines

 Last Update: 2022-08-20
 Source: Internet
 Author: User

Tags

nosema treatment

data application lab

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Chronic prostatitis (CP) has always been a common disease plaguing urologists and has a serious impact on the physical and mental health of patients

Due to the lack of authoritative guidelines for the use of proprietary Chinese medicines in clinical practice, the State Administration of Traditional Chinese Medicine established the standardization project "Guidelines for Clinical Application of Chinese Patent Medicines for the Treatment of Predominant Diseases".

Chinese patent medicine treatment of CP pain and discomfort

Treatment of CP Lower Urinary Tract Symptoms (LUTS) with Proprietary Chinese Medicine

It is recommended to use Shuangshi Tonglin Capsule alone for the treatment of CP with LUTS as the main clinical manifestation, which can improve the clinical symptoms such as urethral burning, frequent urination, and incomplete urine after urination (expert consensus)
.

Dosage: Oral, 4 capsules/time, 3 times/day
.

Treatment of CP with erectile dysfunction by Chinese patent medicine

Combination use of Compound Xuanju Capsules is recommended for the treatment of CP patients with erectile dysfunction, which can improve clinical symptoms such as erectile dysfunction, soreness of waist and knees, lower abdomen, cold penis, and reduction of morning erections (recommendation level 2C)
.

Dosage: Oral, 3 capsules/time, 3 times/day
.

Treatment of CP with sleep disorder by Chinese patent medicine

It is recommended to use Wuling Capsule to treat CP patients with anxiety and depression, which can help relieve the anxiety and depression of CP patients, improve sleep quality, improve life quality, and improve clinical efficacy (expert consensus)
.

Dosage: Oral, 3 capsules/time, 3 times/day
.

references:

Standardization Project Group of "Guidelines for Clinical Application of Chinese Patent Medicines in Treating Predominant Diseases".
Guidelines for Clinical Application of Chinese Patent Medicines in Treating Chronic Prostatitis (2021)[J].
China Journal of Integrated Traditional Chinese and Western Medicine,2022,42(06):653-659.

Editor: Wang Mumu

Reviewer: LR

Executive: Wang Mumu

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.